Guangzhou, Aug 24, 2026 — Guangdong Province expanded its 2026 non-immunization vaccine program by releasing the fourth batch of supplementary products and updating the provincial usage catalog, as the region continues to broaden access to elective vaccines outside the national compulsory immunization schedule.
Policy Snapshot
| Attribute | Detail |
|---|---|
| Issuers | Guangdong Provincial Center for Disease Control and Prevention; Guangdong Drug Exchange Center |
| Document | Notice on the Announcement of Supplementary Products (Fourth Batch) and Updated List of Non-Immunization Vaccines in the 2026 Guangdong Province Vaccination Program |
| Legal basis | Guangdong CDC Bureau [2025] No. 3 (Implementation Plan for Centralized Procurement of Non-Immunization Vaccines in Guangdong Province) |
| Action | Release of fourth supplementary batch; synchronized update of 2026 non-immunization vaccine usage catalog |
| Effective catalog date | Updated to Aug 24, 2026 |
Catalog Updates
The announcement adds a fourth tranche of products to the province’s 2026 non-immunization vaccine directory, which covers elective vaccines outside China’s compulsory national immunization program. The updated catalog, current as of Aug 24, 2026, consolidates all approved non-immunization vaccines available for centralized procurement across Guangdong’s vaccination network.
Market Impact Analysis
The fourth supplementary release signals sustained demand growth for elective vaccines in Guangdong, China’s most populous province with roughly 127 million residents. By maintaining a rolling update mechanism for the non-immunization vaccine catalog, regulators are creating multiple entry windows for manufacturers each year, reducing the barrier for new products to access the provincial market.
For vaccine developers and distributors, inclusion in the updated directory is a prerequisite for participation in Guangdong’s centralized procurement system, which governs public hospital and community health center purchases. The release timing—late August—allows suppliers to position products ahead of the autumn vaccination season, typically a peak period for influenza, pneumococcal, and other elective immunizations.
Forward-Looking Statement
Industry analysts expect Guangdong’s rolling catalog update model to be adopted by additional provinces as China decentralizes non-immunization vaccine procurement authority. The fourth batch release suggests the 2026 program is approaching full coverage scope, though further supplementary announcements before year-end remain possible if new products complete regulatory approval. Manufacturers with pipeline candidates for human papillomavirus, shingles, or combination pediatric vaccines should monitor the Guangdong template closely, as the province’s catalog decisions often influence neighboring jurisdictions in the Pearl River Delta region.-China Health Reform Pulse
For detailed implementation guidelines and the full list of approved products, refer to the official announcements from the Guangdong Provincial Medical Device Exchange Center.
Policy Source: https://www.gdmede.com.cn/announcement/announcement/detail?id=2091877607866896384